China chooses AIDS control model from B.C.

China will follow the example set by an agency in B.C. to set its national HIV/AIDS policy.

The BC Centre for Excellence in HIV/AIDS’ calls for widespread HIV testing and treatment for everyone who is medically-eligible.

In a study published last summer in the Lancet the centre observed that highly active anti-retroviral therapy (HAART) – essentially a cocktail of drugs used to prevent the spread of HIV in the body – halved the number of HIV diagnoses between 1996 and 2009.

China believes that this model of care that will best help it to meet the goal of bringing HIV and AIDS under control there by 2015. The country’s proposal calls for widespread HIV testing and treatment.

More >>

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below